PubMed · 2015 · 12 citations · 9 references
MedicineOncologyPathologyGastrointestinal OncologyMetastasisMolecular OncologyCancer BiomarkersCancer ProgressionChemokine NetworksChemokine SignalingColorectal CancerImmuno-oncology BiomarkersC-c Chemokine Receptor 2 SignalingColonic AdenocarcinomaColorectal Cancer BiomarkersColorectal Cancer PathologyColorectal Cancer PrognosisImmunohistochemical StainingLymph Node Metastasis BiomarkersReverse Transcription Polymerase Chain Reaction (Rt-pcr)
In the present study, we detected CXC chemokine receptor-2 (CXCR2) CXCR2 expression in patients with colorectal cancer (CRC) and investigated the correlation of CXCR2 expression with clinicopathological variables. CXCR2 expression levels in 46 cancerous tissues, 20 colonic benign tumour tissues, and 30 normal colonic mucosa tissues were examined at both the mRNA level and protein level by using reverse transcription polymerase chain reaction (RT-PCR) and two-step immunohistochemical staining, respectively. We found that the positive rate of CXCR2 protein expression in cancer tissue samples was 69.6%. RT-PCR results confirmed that CXCR2 expression was significantly higher in tumour tissues compared with benign tumour and normal mucosa tissues (P < 0.05). When 46 colorectal cancer patients were divided into groups according to the clinical stage, lymph node metastasis and liver metastasis, we found that CXCR2 expression increased in patients with lymph node metastasis (P < 0.05), and its expression was much higher in stage III and IV cancers than stage I and II cancers. These findings suggest that CXCR2 expression in CRC patients may be a potential molecular biomarker for evaluation of tumour growth and invasion.
9
Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8.
Yasuhiko Kitadai, Ken Haruma, Naofumi Mukaida et al. · PubMed · 2000 · 117 citations
Medicine, Cell Biology, Oncology +17